Electromed, Inc. ELMD
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $39.75 (+42.6% upside)
Key Stats
- Today's Range
- $27.35 – $27.97
- 50-Day Range
- $25.81 – $43.74
- 52-Week Range
- $19.93 – $47.40
- Volume
- 93K shs
- Average Volume
- 110K shs
- Market Cap
- $233.25 million
- P/E Ratio
- 21.45
- Dividend Yield
- —
Valuation
- P/E Ratio
- 21.45
- Price / Book
- 4.32
- Price / Sales
- 3.16
Short Interest
- Short Interest
- 0.81%
- Days to Cover
- 4.71
Financials (TTM)
- Revenue
- $73.78 million
- Net Income
- $11.30 million
- Net Margin
- 15.32%
- Return on Equity
- 20.94%
- Debt-to-Equity
- —
About Electromed, Inc.
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.
Related Stocks
Compare head-to-head: ELMD vs MDT·ELMD vs AXGN·ELMD vs BLFS·ELMD vs CNMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.